Levocarnitine

CAS 541-15-1 10 current records 5 historicalSmall Molecule

Who holds supplier records for Levocarnitine? 10 organisations hold a current record for Levocarnitine: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), India (3), United States (1) and France (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Levocarnitine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levocarnitine

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Levocarnitine. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4India3United States1France1Country not recorded for 1
Need Levocarnitine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Levocarnitine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. ShaoxingCN
CEP 2025-034 - Rev 00
Levocarnitine
Apr 2026—
NORTHEAST PHARMACEUTICAL GROUP CO. LTD ShenyangCN
CEP 2022-068 - Rev 01
Levocarnitine
Jul 2025—
CHENGDA PHARMACEUTICALS CO., LTD. JiashanCN
CEP 2019-293 - Rev 02
Levocarnitine
May 2025—
PHARMARESOURCES (KAIYUAN) COMPANY LIMITED Kaiyuan CityCN
CEP 2022-084 - Rev 00
Levocarnitine
Sept 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Levocarnitine are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • NORTHEAST GENERAL PHARMACEUTICAL FACTORY
    Inactive DMF 20102 · filed Nov 2006
  • YONEZAWA HAMARI CHEMICALS LTD
    Inactive DMF 5388, 17647 · filed Aug 2004
  • LONZA LTD
    Inactive DMF 13947 · filed Jan 1999
  • LONZA AG
    Inactive DMF 6892 · filed Mar 1987
  • SIGMA F AND D DIV LTD
    Inactive DMF 3691 · filed Jan 1980

Overview

Levocarnitine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1149).

Chemical identity

IUPAC name
(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate
Canonical SMILES
C[N+](C)(C)C[C@@H](CC(=O)[O-])O
InChIKey
PHIQHXFUZVPYII-ZCFIWIBFSA-N
Synonyms
Carnitor, Carnitor sf, Levocarnitina, Levocarnitine, NSC-759132, L-carnitine, vitamin BT, (-)-Carnitine, (-)-L-Carnitine, Karnitin, L-(-)-Carnitine, Carnitene

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Carnitine Analog
Chemical structure
Carnitine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Levocarnitine?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Levocarnitine: Chengda Pharmaceuticals Co., Ltd. (China), PHARMARESOURCES (KAIYUAN) CO LTD, Zhejiang Bamboo Pharmaceuticals Co.,Ltd (China), Aceto Corporation (United States), API PHARMA TECH LLC (France), GLAND PHARMA LTD (India), METROCHEM API PRIVATE LTD (India) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (China), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Levocarnitine Drug Master Files are active?

Chengda Pharmaceuticals Co., Ltd. (DMF 19142), PHARMARESOURCES (KAIYUAN) CO LTD (DMF 36746), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (DMF 39375), Aceto Corporation (DMF 16150), API PHARMA TECH LLC (DMF 37166), GLAND PHARMA LTD (DMF 39168), METROCHEM API PRIVATE LTD (DMF 38993) and SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (DMF 40803) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Levocarnitine records mean?

5 organisations have only inactive Type II DMFs for Levocarnitine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Levocarnitine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Levocarnitine on the EDQM register, including ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing (CN), NORTHEAST PHARMACEUTICAL GROUP CO. LTD Shenyang (CN), CHENGDA PHARMACEUTICALS CO., LTD. Jiashan (CN) and PHARMARESOURCES (KAIYUAN) COMPANY LIMITED Kaiyuan City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Levocarnitine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Levocarnitine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.